CHICAGO, IL--(Marketwired - Apr 30, 2015) - Elite Investments uncovers unique ideas for Accredited Investors, Fund Managers, and Family Offices. Our bi-monthly free newsletter provides valuable individual public company research, alternative investment ideas, and selective private placement deal flow. In today's blog update we focus on Pernix Therapeutics (
The post can be read on our blog page:
http://eliteinvestments.com/blog/
About Elite Investments:
Generated from our Editor's vast relationships and resources, we identify investing themes and companies that are exceptional and unique. We generate new actionable ideas from some of the smartest institutional investors in the world. Our free newsletter provides valuable individual public company research, alternative investment ideas, and selective private placement deal flow. In today's blog update we have focused on Pernix Therapeutics (
The editor of Elite Investments, Eric Muschinski, is President and CEO of Phenom Ventures, President of Investor Media Inc, and a Director with Equities.com.
Contact Information:
Contact:
Contact:
Eric Muschinski